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Enhanced Inflammation and Accelerated Wound
Closure Following Tetraphorbol Ester Application
or Full-Thickness Wounding in Mice Lacking
Hyaluronan Synthases Has1 and Has3
Judith A. Mack1,2,5, Ron J. Feldman1,2,5, Naoki Itano3, Koji Kimata4, Mark Lauer1, Vincent C. Hascall1
and Edward V. Maytin1,2
Hyaluronan (HA) is an abundant matrix molecule, the function of which in the skin remains to be fully defined. To
explore the roles of HA in cutaneous injury responses, double-knockout mice (abbreviated as Has1/3 null) that lack
two HA synthase enzymes (Has1 and Has3), but still express functional Has2, were used in two types of experiments:
(i) application of 12-O-tetradecanoylphorbol-13-acetate (TPA) and (ii) full-thickness wounding of the skin. Uninjured
Has1/3-null mice were phenotypically normal. However, after TPA, the accumulation of HA that normally occurs in
wild-type epidermis was blunted in Has1/3-null epidermis. In excisional wound-healing experiments, wound closure
was significantly faster in Has1/3 null than in wild-type mice. Coincident with this abnormal wound healing, a
marked decrease in epidermal and dermal HA and a marked increase in neutrophil efflux from cutaneous blood
vessels were observed in Has1/3-null skin relative to wild-type skin. Has1/3-null wounds displayed an earlier onset of
myofibroblast differentiation. In summary, selective loss of Has1 and Has3 leads to a proinflammatory milieu that
favors recruitment of neutrophils and other inflammation-related changes in the dermis.
Journal of Investigative Dermatology (2012) 132, 198–207; doi:10.1038/jid.2011.248; published online 18 August 2011
INTRODUCTION
Hyaluronan (HA) is an abundant extracellular matrix
molecule in the dermis and epidermis of skin, the functions
of which are only now beginning to be elucidated. It is a
linear, non-sulfated glycosaminoglycan comprising long
chains of disaccharides (N-acetyl-glucosamine and glucu-
ronic acid) repeated thousands of times, thereby reaching
4106 kDa in molecular weight (Itano et al., 1999; Itano,
2008). In the epidermis, HA is present in the extracellular
matrix around keratinocytes (Tammi et al., 1988); its rapid
turnover rate (t1/2 of 1–2 days; Tammi et al., 1991) is
determined by a balance between HA degradation (with the
exact hyaluronidases responsible still undetermined) and
synthesis by three HA synthases (Has1, Has2, and Has3) that
when active reside in the plasma membrane (Rilla et al.,
2005). The Has enzymes differ in kinetic properties and
length of the HA chain produced (Itano et al., 1999). HA is
normally extruded directly into the extracellular space (Wang
and Hascall, 2004). The externalized HA interacts with an
HA membrane receptor, CD44, which affects intracellular
signaling and thereby regulates cellular proliferation and
differentiation (Toole, 2004).
The three Has isoforms and their biological activities have
been investigated in gene targeting studies. Functional
deletion of the Has2 gene results in embryonic lethality with
severe cardiac and vascular malformations (Camenisch et al.,
2000). During early embryogenesis, Has2 is responsible for
HA production, and loss of Has2 is not compensated for
by Has1 or Has3. Has3-null (knockout) mice on the other
hand are viable and fertile, with normal life spans (Bai et al.,
2005). Has1-null mice also appear perfectly normal under
non-stressed conditions (Kobayashi et al., 2010).
In the skin, all three HAS enzymes are expressed
throughout the epidermis and dermis (Sugiyama et al.,
1998). Current studies suggest that Has3 may be more highly
expressed in keratinocytes (Sayo et al., 2002), Has1 in
fibroblasts (Yamada et al., 2004), and Has2 in both cell types.
In vitro models have been used to evaluate the role of Has
enzymes during various perturbations of the epidermis.
Treatment of three-dimensional organotypic keratinocyte
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cultures with epidermal growth factor or keratinocyte growth
factor results in increased proliferation, increased Has2 and
Has3 expression, and elevated HA levels (Karvinen et al.,
2003; Pasonen-Seppanen et al., 2003). Physical injury
(needle stick) also triggers HA accumulation in the three-
dimensional organotypic keratinocyte cultures, further sup-
porting a causal relationship between inducible Has2 and
Has3 expression and increased epidermal HA levels after
injury (Monslow et al., 2009). Elevated HA levels are often
observed in hyperproliferative epidermis in the setting of
acute inflammation, so-called inflammatory hyperplasia.
Tape-stripping of the skin, a form of physical injury, induces
epidermal hyperplasia, inflammatory cell infiltration, tran-
sient induction of HA, and elevations in Has2 and Has3
mRNA levels (Tammi et al., 2005). Skin biopsies from
patients with acute eczematous dermatitis (an inflammatory
process) demonstrate increased levels of HA in areas of
spongiosis, mediated by preferential increases in Has3mRNA
expression (Ohtani et al., 2009). Other evidence also suggests
important, complex relationships between the production of
HA, leukocyte recruitment (e.g., gamma/delta T cells), and
cytokine production within cutaneous wounds (Jameson
et al., 2005). Therefore, strong evidence suggests links
between the expression of Has enzymes, accumulation of
HA, dermal inflammatory cell infiltrates, and epidermal
hyperplasia after skin injury. However, how these events
are connected mechanistically remains to be determined.
We used two different injury models to elucidate the
associations between HA, cutaneous inflammation, and
epidermal hyperplasia. The phorbol ester, 12-O-tetradeca-
noylphorbol-13-acetate (TPA), is a well-established pro-
inflammatory agent that stimulates inflammatory cytokine
release, tissue edema, epidermal thickening, and cornified
envelope formation when topically applied (Wang and
Smart, 1999). TPA-driven inflammatory hyperplasia involves
an imbalance between cell-cycle stimulation and growth
arrest (Marks and Furstenberger, 1993), and protein kinase C
isoforms are known to be major regulators (Cataisson et al.,
2005). In studies with protein kinase Ca-overexpressing mice
harboring an epidermally targeted transgene, TPA application
was shown to cause the release of pro-proliferative and
chemotactic factors including tumor necrosis factor-a,
macrophage inflammatory protein-2, keratinocyte, vascular
endothelial growth factor, and GM-CSF (Cataisson et al.,
2005). Another type of skin injury that involves cytokine
release, inflammation, and epidermal hyperplasia is full-
thickness incisional wounding (Singer and Clark, 1999).
Wounding triggers recruitment of leukocytes (neutrophils
first, followed by macrophages) that have roles in modulating
epidermal responses and in regulating the differentiation of
fibroblasts into myofibroblasts (Singer and Clark, 1999).
In this paper, we examined possible links between
changes in HA accumulation and epidermal and dermal
events after skin injury, using a new mouse model that
expresses only one of the HA synthetic enzymes, Has2. These
mice are nullizygous for Has1 and Has3 (abbreviated as
Has1/3 null). In response to skin injury, HA fails to
accumulate in Has1/3-null mice. Using this model, we
show that Has1 and Has3 are dispensable for epidermal
hyperplasia, but are in fact necessary to properly regulate
acute inflammation and fibroblast behavior in the skin
following injury.
RESULTS
Mice harboring deletions in the Has1 gene (Kobayashi et al.,
2010) or the Has3 gene (Bai et al., 2005) were intercrossed to
create Has1/Has3/ animals (Has1/3 null). These mice
appear grossly normal, with good fertility and normal life spans.
Epidermal induction of HA and CD44 following TPA application
is blunted in Has1/3-null mice
Dorsal skin was treated with TPA, and the skin was examined
histologically for changes in morphology, HA, and CD44
(Figure 1). In wild-type (WT) skin, TPA treatment caused
epidermal hyperplasia (compare Figure 1a and d) and a
strong epidermal induction of HA, which rose from nearly
undetectable levels (Tammi et al., 2005) to a very high
amount (compare Figure 1b and e). Immunohistochemical
analysis of CD44 revealed strongly increased expression after
TPA treatment (compare Figure 1c and f). In contrast to WT
mice, Has1/3-null mice showed a blunted response to TPA in
terms of epidermal HA levels (compare Figure 1h and k) and
CD44 (compare Figure 1i and l). Despite the loss of Has1 and
Has3, hyperplastic epidermal thickening in response to TPA
still occurred in Has1/3-null mice, to the same extent as in
WT mice (compare Figure 1g and j).
To confirm these findings by an independent method, an
ELISA-like assay for HA was used (Figure 1m). When
compared with the 6.5-fold increase in HA in WT epidermis
(Figure 1m, left), the 3.6-fold HA induction in Has1/3-null
epidermis was significantly less (Figure 1m, right).
Epidermal induction of Has enzymes after TPA application in
WT and Has1/3-null mice
To understand the basis for increased HA accumulation after
TPA exposure, mRNA expression of HA-synthetic enzymes in
the epidermis was examined. Epidermal sheets from vehicle-
and TPA-treated WT mouse skin were separated and
evaluated by quantitative real-time PCR (Figure 1n, left).
Has3mRNA was preferentially increased by 31-fold, Has2 by
8-fold, and Has1 by 2-fold. In Has1/3-null epidermis, Has2
expression after TPA treatment was examined (Figure 1n,
right), and found to be induced to a nearly identical extent
(9-fold) as in WT epidermis.
Immunostaining revealed identical expression patterns for
markers of keratinocyte proliferation (Ki67) and differentiation
(keratins K10 and K14) in the WT and Has1/3-null epidermis
(data not shown), indicating that Has1/3 mice mount a normal
proliferation and differentiation response to TPA even in the
absence of a full HA induction in the epidermis.
Wound healing in Has1/3-null mice is abnormal, with
accelerated wound closure
In a different model of cutaneous injury, full-thickness
excisional wounds were generated in WT and Has1/3-null
mice, and the course of wound healing in normal versus null
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mice was compared (Figure 2). A striking difference
was observed during the first 9 days after wounding; namely,
the rate of wound closure was higher in Has1/3-null mice
than in WT controls (Figure 2a). Whereas all excisional
wounds in mice tended to stretch and expand during the first
day after wound placement, Has1/3-null wounds had
returned to the initial 5-mm wound diameter by day 3 and
achieved 90% wound closure by day 9. WT wounds did not
reach those benchmarks until days 6 and 10, respectively
(Figure 2b). No other major differences were discernable at a
macroscopic level.
Both epidermal and dermal levels of HA after skin injury are
lower in Has1/3-null mice, relative to WT mice
We were also interested in evaluating HA in the dermis, in
response to TPA and wounding, because dermal HA
constitutes the great majority of HA in the skin. To do this,
we used a biochemical technique called fluorophore-assisted
carbohydrate electrophoresis, which measures the total mass
of HA in tissues (Calabro et al., 2000). We measured total HA in
WT and Has1/3-null skin after full-thickness wounding and in
TPA-treated skin (Figure 3a and b). In WT mice, full-thickness
wounding significantly induces HA levels, by 3 days, toB145%
of control levels. Although a portion of this increase may reflect
increased epidermal HA, as visualized by biotinylated
HA-binding probe staining (Figure 3c), the bulk of the measured
HA accumulation comes from the dermis due to the over-
whelming proportion of HA in the dermal compartment.
In Has1/3-null mice, HA levels in control (uninjured) skin
were similar to levels in WT controls (Figure 3a and b). After
full-thickness wounding, however, the dermal HA content of
Has1/3-null wounds was significantly less than that in WT
wounds (Figure 3a and b), only B55% the level of uninjured
controls. This relative decrease in dermal HA content of Has1/3-
null skin after wounding can also be seen by biotinylated
HA-binding probe staining (Figure 3c, compare lower left
and right panels). Also note that epidermal HA fails to
accumulate in Has1/3-null epidermis (Figure 3c), as was seen
with TPA treatment (Figure 1).
To determine how changes in Has enzyme gene expres-
sion might contribute to the changes in overall HA levels after
full-thickness injury, a time-course experiment using real-
time PCR was conducted to examine Has gene expression
after wounding in WT and Has1/3-null mice (Figure 3d). In
WT mice, strong inductions in Has1 (B100-fold) and Has3
(B200-fold) were observed at 2–6 hours post wounding.
These inductions were transient, declining toward baseline
by B24 hours post wounding. In contrast, Has2 expression
was not induced in WT skin, and in fact declined 2 hours post
wounding. In Has1/3-null wounds, on the other hand, Has2
was strongly induced at all times after wounding. However,
as shown in Figure 3a and b, this upregulation of Has2 was
not sufficient to compensate for loss of Has1 and Has3, as far
as HA induction is concerned.
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Figure 2. Wound closure is accelerated in Has1/3-null mice. (a) Typical examples of 5-mm diameter full-thickness excisional wounds. Wounds were
photographed daily until closure. (b) Graphical summary of changes in wound area, expressed relative to the initial size of the wound at day 0. Data are
mean±SEM; the number of mice analyzed at each time point is shown beneath each data symbol. Open circles, wild type; closed circles, Has1/3 null.
(*), Po0.01; (**), Po0.005 by two-sided Student’s t-test. Has, hyaluronan synthase.
Figure 1. TPA-stimulated accumulation of HA in the epidermis is blunted in Has1/3-null mice. (a–l) Dorsal skin was treated with TPA or vehicle alone
(3 days), biopsied, and evaluated histologically for morphological changes (H&E stains), HA levels (bHABP and streptavidin-Cy3), and CD44 protein levels
(anti-CD44/rhodamine). Specific HA staining was confirmed by pretreatment of specimens with hyaluronidase (e, inset). (m, n) TPA-treated or control epidermis
was separated using dispase, and analyzed for concentrations (ngmg1) of HA using an ELISA-like assay (m), or analyzed for relative expression of Has1,
Has2, and Has3 mRNA using quantitative real-time PCR (qPCR; n). In Has1/3-null skin, only Has2 expression was analyzed. The P-values from two-sided
Student’s t-test are indicated. Dashed/dotted lines: epidermal boundaries . Bar¼ 100 mm. bHABP, biotinylated hyaluronan-binding probe; DAPI,
4,6-diamidino-2-phenylindole; HA, hyaluronan; H&E, hematoxylin and eosin; Has, hyaluronan synthase; mRNA, messenger RNA; TPA,
12-O-tetradecanoylphorbol-13-acetate; WT, wild type.
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Increases in TPA-induced inflammation and wound-induced
inflammation and fibrosis in Has1/3-null skin are associated
with reduced HA levels
Because we observed a decrease in dermal HA in Has1/
3-null injured skin, and knowing that HA influences
inflammation in other systems (Wang and Hascall, 2004;
Wang et al., 2011), we examined inflammatory responses in
our two injury models. After TPA treatment, leukocyte
infiltration into the dermis was greater in Has1/3-null mice
than in control mice (Figure 4a–c), despite the equivalent
amounts of epidermal hyperplasia (Figure 4b and c, double
arrows). This was a mixed inflammatory infiltrate consisting
ofB35% neutrophils (determined by comparing hematoxylin
and eosin stains and neutrophil-specific immunostains using
the RB6/85c antibody; data not shown). Neutrophils dis-
played a 3-fold relative increase after TPA in Has1/3-null
mice (Figure 4j), along with a 5-fold increase in the number
of dilated blood vessels in the upper dermis (Figure 4c and k),
suggesting an increased release of vasodilatory cytokines. In
full-thickness wounds, a preferential increase in neutrophil
c
b
d
No injury Wounded TPA
Quantitation of HA disaccharide bands
R
el
at
iv
e 
am
ou
nt
 o
f H
A 
(%
)
WT WT WTHas1/3
null
Has1/3
null
Has1/3
null
150
100
50
0
P < 0.01
P < 0.005
qPCR analysis of Has gene expression post wounding 
Has1
in WT
Has2
in WT
Has3
in WT
Has2 in
Has1/3
null
R
el
at
iv
e 
(fo
ld)
 ch
an
ge
R
el
at
iv
e 
(fo
ld)
 ch
an
ge
Fo
ld
 c
ha
ng
e
Fo
ld
 c
ha
ng
e
Time (hours) after wounding
200
150
100
50
0
200
300
100
0
62
8
6
4
2
0
0 12 24 620 12 24
0
20
30
40
10
620 12 24620 12 24
bHABP staining of whole skin
N
o 
in
jur
y
W
ou
nd
ed
 (2
4 h
)
Wild-type control
Wild-type, at wound edge
Has1/3-null control
Has1/3-null, at wound edge
a FACE analysis of HA in whole skin
Wild type
Wild type
Wild type
Has1/3 null
Has1/3 null
Has1/3 null
From skin 3 days after wounding
From skin after 3 days TPA application
From non-injured skin
** P < 0.001
**
**
*
*
* *
*
** **
* *
*
*
Figure 3. HA levels are altered in Has1/3-null mice after wounding. (a) Fluorescence-assisted carbohydrate electrophoresis analysis of HA levels in
equivalent amounts (weight) of skin from WT or Has1/3-null mice; treatments as shown. Disaccharide (D di-HA) bands are displayed for individual wounds
(5 mice per condition). (b) Integrated fluorescent intensity of D di-HA bands from 3-day wounds or TPA-treated skin, relative to WT non-injured controls
(mean±SD, n¼5). (c) HA in skin adjacent to incisional wounds (o1mm from wound edge) at 24 hours post injury, immunostained with bHABP/streptavidin-
Cy3. Bar¼ 25 mm. (d) Time course of Has messenger RNA expression post wounding in WT mice or Has1/3-null mice. Mean±SD, duplicate mice,
triplicate qPCR reactions per wound. (*) Significant increase or (**) significant decrease, at Po0.05 level. bHABP, biotinylated hyaluronan-binding probe;
HA, hyaluronan; Has, hyaluronan synthase; qPCR, quantitative real-time PCR; TPA, 12-O-tetradecanoylphorbol-13-acetate; WT, wild type.
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recruitment was also seen in the Has1/3 mice (Figure 4d and
e). During normal wound healing, an influx of neutrophils
begins within a few hours after injury and reaches a
maximum between days 1 and 3 (Dechert et al., 2006). In
WT mice at 24 hours post wounding, neutrophils were
observed transmigrating from vessels of the subdermal
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Figure 4. Preferentially enhanced inflammation in Has1/3-null skin following TPA application (3 days) or full-thickness wounding (24 hours).
(a–c) Hematoxylin and eosin stains of non-injured wild-type, TPA-treated wild-type, or TPA-treated Has1/3-null skin. BV, dilated blood vessels. (d, e) Masson-
Trichrome stains of subdermal vascular plexus (SVP) immediately adjacent to the wound, in wild-type or Has1/3-null mice. Insets, neutrophil-specific
immunostains of the SVP. (f, g) Cartoon of events in wild-type skin after wounding. (h, i) Tissues in the SVP region, costained for HA (green) and neutrophils
(red). Graphs: Data (mean±SEM) for neutrophils (j) and dilated vessels (k) after TPA treatment, or HA staining intensity (l), neutrophils near blood
vessels in the subdermis (m), and neutrophils in the dermis (n) of wounded skin. Bar¼ 50mm. HA, hyaluronan; Has, hyaluronan synthase;
TPA, 12-O-tetradecanoylphorbol-13-acetate; WT wild type.
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vascular plexus (SVP), a region located immediately beneath
the dermis and easily visualized in the skin adjacent to the
wound (Figure 4d; also see the drawings in Figure 4f and g).
In Has1/3-null mice at 24 hours, the number of neutrophils
effluxing from the SVP or present in the dermis was
markedly increased (Figure 4e, m, and n). This increase in
neutrophil recruitment was reflected in the number of
intravascular neutrophil aggregates in the SVP that were
detected in immunostained sections (Supplementary
Figure S1c, c0 online).
Mechanistically, the SVP is of particular interest because
this zone appears to contain the highest HA levels of the
entire skin (Supplementary Figure S1a online) and is a major
site of neutrophil recruitment to vessels (Supplementary
Figure S1b, b0 online). Levels of HA in the SVP region are
reduced in Has1/3-null skin, both in the unwounded situation
(Supplementary Figure S1a0 online) and at 24 hours post
wounding (illustrated in Figure 4h and i, and quantified in
Figure 4l). Notably, double staining for HA and myeloperox-
idase reveals that a robust neutrophil migration from blood
vessels in the SVP appears to be significantly associated with
low HA in the perivascular matrix (Figure 4i and m).
A time-course experiment provided further evidence that
neutrophil recruitment is accelerated in the Has1/3-null
wounds. Whereas more neutrophils were seen at day 1,
fewer were seen at day 5 (relative to WT wounds), an
observation consistent with faster resolution of the neutro-
philic infiltrate (Supplementary Table S1 online), although
more detailed experiments will be needed to confirm this
point. Macrophages, on the other hand, showed similar
behavior in the Has1/3-null and WT wounds, first appearing
at day 3 and becoming equally abundant at days 5 and 10
(Supplementary Table S1 online).
We also examined the dermal and subcutaneous regions
for evidence of relative changes in fibroblast proliferation and
differentiation. The results suggest an earlier onset of
myofibroblast differentiation in the Has1/3-null wounds
(Supplementary Table S1 online). Beginning at day 5 after
wounding, spindle-shaped cells (many of which expressed a-
smooth muscle actin; Supplementary Figure S1d, d0 online)
appeared in Has1/3-null skin at the wound edge and beneath
the wound bed, but were much less evident in the WT
wounds.
DISCUSSION
In this study, we examined the epidermal and dermal injury
responses in mice lacking Has1 and Has3, as compared with
WT mice. Levels of HA, expression of Has enzymes,
inflammation, and fibroblast behavior were evaluated. Two
different kinds of injury, TPA and wounding, were used. For
both types of injury, similarities in HA responses in the
epidermis and in the dermis were noted as follows. In normal
epidermis, large accumulations of HA were observed, both
after TPA (Figure 1e) and after wounding (Figure 3c). In Has1/
3-null epidermis, HA accumulations were smaller than in WT
epidermis, but some HA induction was still observed. Levels
of CD44 (the HA receptor) on keratinocyte plasma mem-
branes appeared to correlate with overall HA levels (Figure 1),
consistent with suggestions that CD44 levels are controlled
by the receptor internalization rate; this rate is slowed when
CD44 is retained on the surface through binding to
extracellular HA ligand (Knudson et al., 2002). In the dermis,
changes were more difficult to interpret. In WT skin, dermal
HA was increased after wounding (up B145%) but not after
TPA (Figure 3a and b). In Has1/3-null skin, on the other hand,
either wounding or TPA exposure led to a decline in dermal
HA of approximately 40–50% (Figure 3b). We can only
speculate that this decline is the result of dermal hyalur-
onidase activity, which becomes unopposed by HA synthesis
in mice that lack both Has1 and Has3.
Our data also provide information on the relative
contribution that changes in Has1, 2, and 3 expression may
be making to the accumulation of HA in epidermal and
dermal compartments after injury. Epidermal Has1 expres-
sion remains low (essentially unchanged) after TPA exposure
in WT mice (Figure 1n), suggesting that Has2 and Has3
(which are significantly induced after TPA) are the principal
enzymes responsible for HA accumulation in the epidermis
following TPA. Has2 is induced to the same extent in Has1/
3-null epidermis as in WT epidermis (8-fold in each case,
Figure 1n) following TPA injury, which appears to explain
why significant amounts of HA can still be synthesized in the
Has1/3-null mice (Figure 1m). In the dermis, however, both
Has1 and Has3 are highly induced post wounding, whereas
Has2 is not. This indicates that Has3 is a major responder
following both types of injury, and in both tissue compart-
ments. Interestingly in Has1/3-null mice, a compensatory
increase in dermal Has2 expression is observed after
wounding as compared with WT mice (Figure 3d); this could
have functional implications, as discussed further below.
Two injury phenotypes, to our knowledge previously
unreported, are observed in Has1/3-null mice: (i) faster
wound closure than in WT mice (Figure 2), and (ii) an
exaggerated neutrophil recruitment following cutaneous
injury (Figure 4). Has1/3-null wounds were smaller at all
time points measured. The enhanced population of myofi-
broblasts beginning at day 5 in null wounds could account for
the faster closure at day 5 and beyond. At earlier time points
(days 1 and 3), the lower amounts of HA inHas1/3-null wounds
could lead to drier, less edematous tissue (as HA is very
hydrophilic), and hence to a smaller wound size. Alternatively,
cytokines released by neutrophils in Has1/3-null wounds may
stimulate premature wound contraction through increased
fibroblast cytoskeletal contractility, even in the absence of
myofibroblast transformation (Vishwanath et al., 2003).
Neutrophils are important participants in a number of
inflammatory responses of the skin. In mice, repeated
treatment with topical TPA results in a temporal influx of
neutrophils that becomes maximal at 3 days (Alford et al.,
1992). After acute wounding, neutrophil influx into the skin is
detectable by 4 hours, and plateaus at B3 days (Dechert
et al., 2006; Kim et al., 2008). Because the half-life of
neutrophils is only a few hours (Kim et al., 2008), neutrophil
accumulation at wound sites must reflect continuous recruit-
ment of circulating neutrophils, regulated in some manner by
HA. In Has1/3-null mice, reduced levels of dermal HA are
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associated with an increase in neutrophils at the injury site. In
our search for the mechanistic link between HA and
enhanced neutrophil recruitment, we hypothesize that
reduced HA in Has1/3-null venular walls (Figure 4) at sites
of injury results in increased neutrophil adhesion. Other
studies have shown that HA reduces neutrophil adhesion
to human endothelial vein cells in vitro (Forrester and
Wilkinson, 1981; Alam et al., 2005), and that adhesion of
neutrophils to postcapillary venules in vivo after PMA
treatment is inhibited by intravenous administration of HA
(Alam et al., 2005). An additional hypothesis to explain
enhanced neutrophil influx into HA-deficient Has1/3-null
dermis is that HA inhibits neutrophil migration (Alstergren
et al., 2004). For example, HA-rich tissues (e.g., cartilage;
vitreous of the eye) are resistant to influxes of inflammatory
cells (Forrester and Lackie, 1981). Other indirect mechanisms
may exist. For instance, the synthesis or release of neutrophil
chemotactic factors such IL-6 or IL-8 (Pauloin et al., 2009)
might be altered.
Two additional points of interest can be noted regarding
functions of Has enzymes in the skin. First, epidermal
hyperplasia still occurs in Has1/3-null mice despite a failure
to induce high levels of HA. Therefore, massive epidermal
accumulation of HA is not required for epidermal hyperplasia
following TPA, but at least some HA may still be needed for
proper epidermal proliferation and stratification as Has2 is
still expressed in Has1/3-null epidermis. Partial functional
redundancy was described in mice hemizygous for Has2 and
nullizygous for Has3 (Has2þ /, Has3/; McDonald and
Camenisch, 2002; Spicer et al., 2002), suggesting that partial
compensation by Has2 is likely in the Has1/3-null mice.
Second, our data support a role for all three Has enzymes in
cutaneous responses after injury. In the WT epidermis, mRNA
expression of Has3 and Has2 was increased more than Has1
after TPA stimulation (Figure 1n). In wounded WT whole
skin, both Has1 and Has3 were induced, whereas Has2
expression actually declined (Figure 3d). This suggests that
the relative contribution of different Has enzymes to HA
production is dynamic and cell specific, and might contribute
to subsequent events through different mechanisms. First,
because the average polymer length of HA synthesized by
each type of Has enzyme is different (Has1¼Has24Has3), a
change in the relative amounts of each Has could differen-
tially affect cellular responses. For example, lower-mass HA
(o200,000 kDa), such as that produced by Has3, can more
efficiently activate intracellular signaling via CD44 (Tammi
et al., 2002). Second, as mentioned above, different cell types
may express distinctly different levels of each Has, leading to
different cell-specific responses for keratinocytes, vascular
endothelium, and fibroblasts after injury. Other investigators
have noted the relative importance of Has3 in keratinocytes
under basal conditions (Sayo et al., 2002), in response to
inflammatory cytokines (Ohtani et al., 2009), and during
epidermal hyperplasia caused by sonophoresis (Lee et al.,
2009). TPA can promote phosphorylation of Has3 on a
critical serine residue (Goentzel et al., 2006), and phosphor-
ylation regulates Has3 activity (Vigetti et al., 2009). In mice
subjected to ventilator-induced lung injury, Has3 was
required to generate low-molecular-weight HA, accompa-
nied by induction of macrophage inflammatory protein-2 and
a neutrophilic infiltrate (Bai et al., 2005).
For other tissues, however, Has2 may be of relatively
greater importance. In mice, conditional inactivation of Has2
leads to disruption in mesenchymal (as opposed to epithelial)
compartments, including defects in skeletal and cartilage
development (Matsumoto et al., 2009). In the skin of Has1/
3-null mice, we have shown that Has2 expression cannot
compensate quantitatively for the loss of dermal HA levels.
However, the increased Has2 observed in Has1/3-null
wounds may be contributing to a profibrotic phenotype.
Has2 has been implicated in fibrosis following lung injury
(Heldin et al., 2008), and is thought to have an important role in
fibroblast to myofibroblast conversion (Webber et al., 2009).
Finally, we cannot rule out the possibility that Has2 induced in
Has1/3-null skin (Figure 3d) may cause a qualitative change in
HA produced at specific locations within the dermis, thus
contributing to the proinflammatory milieu.
In summary, our study demonstrates that the balance of
HA produced by distinct Has enzymes is important for
regulating inflammatory responses and wound contraction in
the skin after injury. Future studies will address the question
of whether altered HA patterns in Has1/3-null mice can affect
long-term scar formation and tensile strength, keeping in
mind that faster healing does not necessarily mean better
quality healing. Although detailed mechanisms remain to be
determined, areas to focus on will be the role of HA in and
around venules during neutrophil recruitment, and the role
that dermal HA has in the proliferation and differentiation of
myofibroblasts.
MATERIALS AND METHODS
Animals
C57BL/6J mice were obtained from JAX Laboratories (Bar Harbor,
ME). Has1/ mice (Kobayashi et al., 2010) and Has3/ mice (Bai
et al., 2005) were generated previously using a strategy that
eliminates the catalytic site of each enzyme. Has1/ and Has3/
mice were intercrossed to generate animals nullizygous for both
alleles (Has1/3 null). All mice were maintained in accordance with
guidelines of the American Association for the Accreditation of
Laboratory Animal Care, and were approved by our Institutional
Animal Care and Use Committee.
Injury with TPA
For TPA experiments, dorsal skin of 6- to 10-week-old mice was
shaved 48 hours before application. TPA (Sigma, St Louis, MO) was
prepared (5mg, dissolved in 20ml DMSO, and then diluted to
100ml in acetone) and applied to the animal’s back with a cotton
swab and gently rubbed (10 mg per application; twice daily for 3
days). Mice were euthanized 2 hours after the last treatment, and the
skin harvested, fixed in 4% paraformaldehyde, and embedded in
paraffin.
Wound-healing experiments
All procedures were preapproved by our institution’s Animal Care
and Use Committee. Mice (C57/BL6 WT, or Has1/3 null, 9–10 weeks
of age) were anesthetized with pentobarbital and fur shaved from the
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upper back. To create full-thickness excisional wounds (one wound
per mouse), a 5-mm circular template of sticky tape (cut with a
biopsy punch) was placed B1 cm posterior to the ears. A 5-mm
excisional wound was created down to fascia, using fine iris scissors.
At specified times (from 0 to 11 days), mice were anesthetized with
isofluorane and photographed at a fixed distance using a digital
camera on a stand. The area of wounds was determined from the
digital photos, using image software (pixel counts).
For histological examination, wounds were harvested at 0, 1, 3, 5,
and 10 days post wounding along with unwounded skin. A B1cm
square of tissue around the wound and beneath the dermis was
collected by careful dissection, placed on a piece of chromatography
paper (with the orientation noted by marking the caudal pole with a
pen). The tissue was bisected with a razor blade oriented in the
cephalad–caudad direction. Tissue was fixed in Histochoice (Amresco,
Solon, OH), paraffin embedded, and stored for later sectioning.
Full-thickness linear incisional wounds (1.5 cm long) were made
with iris scissors and closed using 6–0 nylon interrupted sutures.
Wounds were harvested at 2, 6, 12, and 24 hours post wounding
(2mm of tissue on either side of the incision). Tissue was frozen and
stored at 80 1C for subsequent RNA isolation.
Histology and immunohistochemistry
Histochoice-fixed or 4% paraformaldehyde-fixed, 5mm paraffin
sections were stained with hematoxylin and eosin using standard
methods. For collagen visualization, the Masson Trichrome staining
kit (Thermo Fisher Scientific, Pittsburgh, PA) was used according to
the manufacturer’s protocol. For detection of HA, sections were
rehydrated and HA visualized by immunofluorescence using a
biotinylated HA-binding probe and streptavidin-Cy3 (Passi et al.,
2004). For standard immunohistochemistry, the antibodies and
staining conditions are described in Supplementary Materials and
Methods online.
Quantitation of HA by ELISA-like assay
Solubilized tissues (either from whole skin adjacent to wounds or
from dispase-separated epidermis) were prepared and analyzed in a
competitive ELISA-like assay for HA, modified from Fosang et al.
(1990). Details are provided in Supplementary Materials and
Methods online.
Quantitation of HA by fluorophore-assisted carbohydrate
electrophoresis
Fluorophore-assisted carbohydrate electrophoresis, a technique that
quantifies total HA mass, was performed as described previously
(Calabro et al., 2000; Passi et al., 2004).
RNA isolation and quantitative real-time PCR analysis
RNA was prepared from total skin adjacent to full-thickness
incisional wounds, or from dispase-separated epidermis after TPA
treatment, then reversed transcribed and subjected to quantitative
real-time PCR (Schmittgen and Livak, 2008) as described in
Supplementary Materials and Methods online.
Digital image analysis of histological sections
Histological specimens were visualized on an Olympus BX-50
microscope (Olympus, Tokyo, Japan) with epifluorescence attachments
and a Polaroid DU-DMC2 digital camera (Polaroid, Waltham, MA).
Image processing was done with IPLab Spectrum software (Scanalytics,
Rockville, MD) as described (Maytin et al., 2004).
Statistical analysis
Differences between experimental and control groups were eval-
uated with a two-sided Student’s t-test, assuming equal variance in
each group. A P-value of 0.05 or less was considered significant.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We thank Jamie Monslow, PhD, for help in developing the quantitative real-
time PCR assays. This work was supported in part by NIH/NIAMS grants R01
AR049249 (to EVM) and R56 AR049249 (to EVM), NlH/NHLBl grant P01
HL107147 (to VCH), and a grant from the Women’s Dermatologic Society
(to RJF).
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at http://
www.nature.com/jid
REFERENCES
Alam CA, Seed MP, Freemantle C et al. (2005) The inhibition of neutrophil-
endothelial cell adhesion by hyaluronan independent of CD44.
Inflammo Pharmacology 12:535–50
Alford JG, Stanley PL, Todderud G et al. (1992) Temporal infiltration of
leukocyte subsets into mouse skin inflamed with phorbol ester. Agents
and Actions 37:260–7
Alstergren P, Zhu B, Glogauer M et al. (2004) Polarization and directed
migration of murine neutrophils is dependent on cell surface expression
of CD44. Cell Immunol 231:146–57
Bai KJ, Spicer AP, Mascarenhas MM et al. (2005) The role of hyaluronan
synthase 3 in ventilator-induced lung injury. Amer J Resp Crit Care Med
172:92–8
Calabro A, Benavides M, Tammi M et al. (2000) Microanalysis of
enzyme digests of hyaluronan and chondroitin/dermatan sulfate by
fluorophore-assisted carbohydrate electrophoresis (FACE). Glycobiology
10:273–81
Camenisch TD, Spicer AP, Brehm-Gibson T et al. (2000) Disruption of
hyaluronan synthase-2 abrogates normal cardiac morphogenesis and
hyaluronan-mediated transformation of epithelium to mesenchyme.
J Clin Invest 106:349–60
Cataisson C, Pearson AJ, Torgerson S et al. (2005) Protein kinase C alpha-
mediated chemotaxis of neutrophils requires NF-kappa B activity but is
independent of TNF alpha signaling in mouse skin in vivo. J Immunol
174:1686–92
Dechert TA, Ducale AE, Ward SI et al. (2006) Hyaluronan in human
acute and chronic dermal wounds. Wound Repair Regen 14:
252–8
Forrester JV, Lackie JM (1981) Effect of hyaluronic acid on neutrophil
adhesion. J Cell Sci 50:329–44
Forrester JV, Wilkinson PC (1981) Inhibition of leukocyte locomotion by
hyaluronic acid. J Cell Sci 48:315–31
Fosang AJ, Hey NJ, Carney SL et al. (1990) An ELISA plate-based assay for
hyaluronan using biotinylated proteoglycan G1 domain (HA-binding
region). Matrix 10:306–13
Goentzel BJ, Weigel PH, Steinberg RA (2006) Recombinant human
hyaluronan synthase 3 is phosphorylated in mammalian cells. Biochem
J 396:347–54
Heldin P, Karousou E, Bernert B et al. (2008) Importance of hyaluronan-CD44
interactions in inflammation and tumorigenesis. Connective Tiss Res
49:215–8
206 Journal of Investigative Dermatology (2012), Volume 132
JA Mack et al.
Inflammation and Wound Healing in Has1/Has3-Null Mice
Itano N (2008) Simple primary structure, complex turnover regulation, and
multiple roles of hyaluronan. J Biochem 144:131–7
Itano N, Sawai T, Yoshida M et al. (1999) Three isoforms of mammalian
hyaluronan synthases have distinct enzymatic properties. J Biol Chem
274:25085–92
Jameson JM, Cauvi G, Sharp LL et al. (2005) Gammadelta T cell-induced
hyaluronan production by epithelial cells regulates inflammation. J Exper
Med 201:1269–79
Karvinen S, Pasonen-Seppanen S, Hyttinen JM et al. (2003) Keratinocyte
growth factor stimulates migration and hyaluronan synthesis in the
epidermis by activation of keratinocyte hyaluronan synthases 2 and 3.
J Biol Chem 278:49495–504
Kim MH, Liu W, Borjesson DL et al. (2008) Dynamics of neutrophil
infiltration during cutaneous wound healing and infection using
fluorescence imaging. J Invest Dermatol 128:1812–20
Knudson W, Chow G, Knudson CB (2002) CD44-mediated uptake and
degradation of hyaluronan. Matrix Biol 21:15–23
Kobayashi N, Miyoshi S, Mikami T et al. (2010) Hyaluronan deficiency in
tumor stroma impairs macrophage trafficking and tumor neovasculariza-
tion. Cancer Res 70:7073–83
Lee SE, Jun JE, Choi EH et al. (2009) Stimulation of epidermal calcium
gradient loss increases the expression of hyaluronan and CD44 in mouse
skin. Clin Exper Dermatol 35:650–7
Marks F, Furstenberger G (1993) Proliferative responses of the skin to external
stimuli. Environ Health Perspect 101(Suppl 5):95–101
Matsumoto K, Li Y, Jakuba C et al. (2009) Conditional inactivation of Has2
reveals a crucial role for hyaluronan in skeletal growth, patterning,
chondrocyte maturation and joint formation in the developing limb.
Development 136:2825–35
Maytin EV, Chung HH, Seetharaman VM (2004) Hyaluronan participates in
the epidermal response to disruption of the permeability barrier in vivo.
Am J Pathol 165:1331–41
McDonald JA, Camenisch TD (2002) Hyaluronan: genetic insights
into the complex biology of a simple polysaccharide. Glycoconjugate J
19:331–9
Monslow J, Sato N, Mack JA et al. (2009) Wounding-induced synthesis of
hyaluronic acid in organotypic epidermal cultures requires the release of
heparin-binding egf and activation of the EGFR. J Invest Dermatol
129:2046–58
Ohtani T, Memezawa A, Okuyama R et al. (2009) Increased hyaluronan
production and decreased E-cadherin expression by cytokine-stimulated
keratinocytes lead to spongiosis formation. J Invest Dermatol
129:1412–20
Pasonen-Seppanen S, Karvinen S, Torronen K et al. (2003) EGF upregulates,
whereas TGF-beta downregulates, the hyaluronan synthases Has2 and
Has3 in organotypic keratinocyte cultures: correlations with epidermal
proliferation and differentiation. J Invest Dermatol 120:1038–44
Passi A, Sadeghi P, Kawamura H et al. (2004) Hyaluronan suppresses
epidermal differentiation in organotypic cultures of rat keratinocytes.
Exper Cell Res 296:123–34
Pauloin T, Dutot M, Liang H et al. (2009) Corneal protection with high-
molecular-weight hyaluronan against in vitro and in vivo sodium lauryl
sulfate-induced toxic effects. Cornea 28:1032–41
Rilla K, Siiskonen H, Spicer AP et al. (2005) Plasma membrane residence of
hyaluronan synthase is coupled to its enzymatic activity. J Biol Chem
280:31890–7
Sayo T, Sugiyama Y, Takahashi Y et al. (2002) Hyaluronan synthase 3
regulates hyaluronan synthesis in cultured human keratinocytes. J Invest
Dermatol 118:43–8
Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the
comparative C(T) method. Nat Protoc 3:1101–8
Singer AJ, Clark RAF (1999) Cutaneous wound healing. N Engl J Med
341:738–46
Spicer AP, Tien JL, Joo A et al. (2002) Investigation of hyaluronan function in
the mouse through targeted mutagenesis. Glycoconjugate J 19:341–5
Sugiyama Y, Shimada A, Sayo T et al. (1998) Putative hyaluronan
synthase mRNA are expressed in mouse skin and TGF-beta upregulates
their expression in cultured human skin cells. J Invest Dermatol
110:116–21
Tammi MI, Day AJ, Turley EA (2002) Hyaluronan and homeostasis: a
balancing act. J Biol Chem 277:4581–4
Tammi R, Pasonen-Seppanen S, Kolehmainen E et al. (2005) Hyaluronan
synthase induction and hyaluronan accumulation in mouse epidermis
following skin injury. J Invest Dermatol 124:898–905
Tammi R, Ripellino JA, Margolis RU et al. (1988) Localization of epidermal
hyaluronic acid using the hyaluronate binding region of cartilage
proteoglycan as a specific probe. J Invest Dermatol 90:412–4
Tammi R, Saamanen AM, Maibach HI et al. (1991) Degradation of newly
synthesized high molecular mass hyaluronan in the epidermal and
dermal compartments of human skin in organ culture. J Invest Dermatol
97:126–30
Toole BP (2004) Hyaluronan: from extracellular glue to pericellular cue. Nat
Rev Cancer 4:528–39
Vigetti D, Genasetti A, Karousou E et al. (2009) Modulation of hyaluronan
synthase activity in cellular membrane fractions. J Biol Chem 284:
30684–94
Vishwanath M, Ma L, Otey CA et al. (2003) Modulation of corneal fibroblast
contractility within fibrillar collagen matrices. Invest Ophthalmol Vis Sci
44:4724–35
Wang A, de la Motte C, Lauer M et al. (2011) Hyaluronan matrices in
pathobiological processes. FEBS J 278:1412–8
Wang A, Hascall VC (2004) Hyaluronan structures synthesized by rat
mesangial cells in response to hyperglycemia induce monocyte
adhesion. J Biol Chem 279:10279–85
Wang HQ, Smart RC (1999) Overexpression of protein kinase C-alpha in the
epidermis of transgenic mice results in striking alterations in phorbol
ester-induced inflammation and COX-2, MIP-2 and TNF-alpha expres-
sion but not tumor promotion. J Cell Sci 112(Part 20):3497–506
Webber J, Meran S, Steadman R et al. (2009) Hyaluronan orchestrates
transforming growth factor-beta1-dependent maintenance of myofibro-
blast phenotype. J Biol Chem 284:9083–92
Yamada Y, Itano N, Hata K et al. (2004) Differential regulation by
IL-1beta and EGF of expression of three different hyaluronan synthases
in oral mucosal epithelial cells and fibroblasts and dermal fibroblasts:
quantitative analysis using real-time RT-PCR. J Invest Dermatol
122:631–9
www.jidonline.org 207
JA Mack et al.
Inflammation and Wound Healing in Has1/Has3-Null Mice
